ArticleResearch square2026

First-line dolutegravir/lamivudine penetrates lymph nodes and reduces HIV reservoirs comparably to triple therapy.

Jose Molto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.